Skip to content

A multi-center clinical study on the treatment of Parkinson's disease by TCM syndrome differentiation

A multi-center clinical study on the treatment of Parkinson's disease by TCM syndrome differentiation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011949
Enrollment
Unknown
Registered
2017-07-11
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Treatment group:Chinese traditional medicine formula granule

Sponsors

Longhua hospital affiliated to Shanghai university of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Early PD patients, in accordance with PD western medicine diagnostic criteria and H-Y grade=3.0; 2. aged between 30 and 80 years old; 3. voluntary participation and signing informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients recieved other types of anti-parkinson s disease drugs such as amantadine, Trihexyphenidyl, Pramipexole, selegiline; 2. secondary Parkinson's disease; 3. with other serious central nervous system diseases; 4. with cardiovascular,respiratory, kidney system serious illness, mental patients; 5. history of alcohol or drug abuse; 6. during pregnancy and lactation women.

Design outcomes

Primary

MeasureTime frame
UPDRS;on-off phenomenon;The function obstacle of senile fibrillation in traditional Chinese medicine;improved Hoehn-Yahr Grade;Levodopa dosage;SCOPA-AUT;PDSS;HAMD;MMSE;PDQ-39;

Countries

China

Contacts

Public ContactYuan Canxing

Longhua hospital affiliated to Shanghai university of traditional Chinese medicine

yeqing1982889@163.com+86 13611669686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026